Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of AGR Tablet for perennial allergic rhinitis in Korean patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Nonseasonal Allergic Rhinitis
• Perennial Allergic Rhinitis

Drugs mentioned

• AGR Tablet

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED